5-Hour Energy: A Success Equal Parts Caffeine, Chemistry and…
Suddenly, Amazon Doesn't Love Its Moms Anymore
Today was simple. It's all about employment. A better than expected labor report sent shares soaring. The notion that a late day report showing that credit to Americans is still declining was largely ignored. The unemployment data was good enough that some might even question it. Either way, it looks like the only group losing droves of jobs now is the group of market bears. Here were today's unofficial closing bell levels:DJIA:9,730.07(+1.23%)
S&P500:1,010.47(+1.35%)
NASDAQ:2,000.25(+1.37%)
Top 10 Analyst Calls
Opexa Therapeutics, Inc. (NASDAQ: OPXA) sold some stem cell technology to Novartis (NYSE: NVS) for $3 million up front, but it is getting another $1 million over six months and the company could get another $50 million from royalties and milestone hurdles. Shares were up a sharp and whopping 300% at $1.89 right before the close.
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
